In a study of hemodialysis patients, mortality risk increased along with phosphorus level, particularly among patients with higher residual renal urea clearance.
Following radical cystectomy for bladder cancer, end-stage renal disease patients are 3-4 times more likely to die from causes other than cancer.
In a study, vonapanitase did not improve primary patency compared with placebo, but did improve secondary patency and fistula use for hemodialysis.
Among hemodialysis patients, sudden cardiac death accounted for 12% more cardiovascular-related mortalities in 2013 than in 2009.
ESRD patients aged 60-64 years with no insurance or who are on Medicaid are less likely to initiate peritoneal dialysis.
Ferric pyrophosphate citrate delivered via dialysate or intravenously rapidly donates iron to transferrin and is rapidly cleared from the circulation.
Nearly a quarter of hospitalizations are followed by readmission within 30 days for non-elective reasons.
Study documents an upswing in emergency department visits and observation stays.
Patients in the lowest quartile of mortality risk were more likely to be screened for colon cancer than those in the highest quartile.
In-hospital mortality following RFA was higher in older, dialyzed ESRD patients than in non dialyzed patients.
Patients with early and frequent nephrology visits before dialysis initiation had about a 10% lower risk for major adverse cardiovascular events.
Decreased use of erythropoiesis-stimulating agents and an uptick in peritoneal dialysis use are among the trends.
ESRD sufferers in the US illegally seek hospital emergency departments with distressing symptoms.
Patients on chronic hemodialysis with depression are frequently not interested in modifying or initiating antidepressant treatment, commonly attributing their depression to a recent acute event, chronic illness, or dialysis.
Dialysis facilities with the least control of PTH, Ca, and P had the greatest risks.
Patients feel better and recovery times are shorter with 6 hemodialysis sessions per week rather than 3, researchers report.
Participants experienced poor sleep quality, increased daytime sleepiness, as well as restless leg syndrome due to maintenance hemodialysis.
An enzyme that inhibits vascular calcification depends on the vitamin for conversion to its active form.
Researchers reported a 47% AVF failure rate for both fish oil and placebo recipients.
The study shows that simple, home-based exercise programs hold potential for improving physical functioning in dialysis patients.
Younger patients are less likely to respond to treatment with sucroferric oxyhydroxide or sevelamer.
Pending future research, patients should avoid taking more than 120 mg per day.
Their risk of the rare but life-threatening condition is twice as high as in hemodialysis patients.
Study reveals a link between higher BMI in HD patients and greater incorporation of omega-3 fatty acids into red blood cell membranes.
Cardiovascular events more than tripled 4 days following the last dialysis session.
It can sharply lower serum phosphorus levels and reduce dependence on phosphate binders.
Study finds no increased risk of major adverse cardiovascular events and death.
A low protein, low phosphorus diet plays an important role in the nutritional management of patients transitioning to once-weekly incremental hemodialysis.
A workgroup has developed guidelines for the use of hemodialysis treatments for common toxicities
In a study, extended-hours versus conventional HD was associated with a 33% decreased mortality risk
Renal and Urology News Articles
- Renal, Bladder Cancer Linked to Physical Inactivity
- Residual Kidney Function Predicts Mortality in CKD-MBD
- Keytruda Approved for All Cancers With Specific Genetic Biomarker
- Pure Bladder Cancer Variants Linked to Worse Survival After RC
- Combined Urinary Testing Helps Detect Aggressive PCa, Avoid Biopsy
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)